Shire plc

    Shire plc

    NNASDAQ:SHPG
    - -
    USD
    - -
    - -
    11.45P/E
    2005 Y
    2006 Y
    2007 Y
    2008 Y
    2009 Y
    2010 Y
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    TTM
    Revenue per Share
    9.59
    10.71
    13.53
    16.74
    16.69
    19.06
    23.21
    25.29
    26.82
    30.79
    32.61
    44.4
    50.17
    51.7
    Basic EPS, GAAP
    -2.46
    1.66
    -8.06
    0.86
    2.73
    3.23
    4.71
    4.03
    3.61
    17.41
    6.62
    1.28
    14.14
    15.83
    Free Cash Flow per Basic Share
    1.77
    2.22
    1.7
    2.99
    2.03
    3.44
    4.76
    6.43
    7.1
    21.23
    11.29
    7.83
    11.44
    11.62
    Dividend per Share
    0.17
    0.19
    0.23
    0.26
    0.3
    0.34
    0.4
    0.47
    0.52
    0.62
    0.68
    0.67
    0.93
    1.06
    Book Value per Share
    2.48
    2.36
    -6.06
    -5.52
    -3.14
    -0.57
    3.04
    5.68
    8.26
    24.04
    29.71
    23.4
    33.1
    37.98
    Tangible Book Value per Share
    4.15
    5.62
    -4.2
    -4.86
    -1.46
    0.38
    0.54
    4.19
    13.2
    6.41
    -17.74
    -92.08
    -55.27
    -37.64
    Basic Weighted Avg Shares
    167
    168
    180
    181
    180
    182
    184
    185
    184
    196
    197
    257
    302
    304
    Sales/Revenue/Turnover
    1,599
    1,797
    2,436
    3,022
    3,008
    3,471
    4,263
    4,681
    4,934
    6,022
    6,417
    11,397
    15,161
    15,702
    Operating Margin (%)
    -21.56
    16.08
    20.06
    22.34
    21.4
    24.1
    27.05
    20.43
    34.43
    35.53
    34.07
    17.13
    22.41
    25.89
    Depreciation Expense
    72
    104
    172
    203
    250
    256
    295
    309
    152
    407
    637
    1,466
    1,768
    2,296
    Net Income, GAAP
    -411
    278
    -1,452
    156
    492
    588
    865
    745
    665
    3,406
    1,303
    327
    4,272
    4,809
    Effective Tax Rate (%)
    - -
    26.8
    - -
    36.9
    21.54
    23.75
    20.88
    18.32
    16.41
    1.68
    3.33
    - -
    - -
    51.87
    Profit Margin (%)
    -25.69
    15.49
    -59.59
    5.16
    16.34
    16.94
    20.29
    15.92
    13.48
    56.55
    20.31
    2.87
    28.18
    30.63
    Working Capital
    347
    478
    435
    221
    550
    587
    -326
    1,567
    2,480
    2,161
    -1,451
    -204
    -274
    -712
    LT Debt
    - -
    - -
    1,133
    1,143
    1,144
    1,108
    - -
    1,100
    - -
    - -
    70
    19,900
    16,752
    11,098
    Total Equity
    1,789
    1,942
    1,227
    1,298
    1,913
    2,451
    3,185
    3,809
    5,366
    8,663
    9,829
    28,948
    36,176
    37,290
    Return on Invested Capital (%)
    - -
    10.25
    - -
    17.41
    18.17
    19.15
    23.22
    16.88
    27.38
    28.24
    20.18
    - -
    - -
    - -
    Return on Capital (%)
    - -
    73.14
    - -
    262.12
    144.48
    77.81
    67.32
    40.77
    37.97
    97.16
    20.7
    - -
    - -
    51.62
    Return on Common Equity (%)
    -64.96
    68.62
    - -
    - -
    - -
    - -
    - -
    92.61
    51.73
    109.46
    24.71
    5.52
    53.36
    52.04

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'18
    Jun'18
    Sep'18
    ST Debt
    1,787
    1,193
    4,249
    LT Borrowings
    16,392
    16,383
    10,741
    LT Finance Leases
    342
    339
    357
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    911
    913
    915
    Market Capitalization
    45,162
    51,117
    55,050

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'18
    Jun'18
    Sep'18
    Total Current Assets
    7,915
    9,788
    7,799
    Cash, Cash Equivalents & STI
    318
    260
    193
    Accounts Receivable, Net
    3,141
    3,005
    3,207
    Inventories
    3,341
    3,353
    3,459
    Total Current Liabilities
    6,945
    6,307
    8,512
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1,787
    1,193
    4,249
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    46.61%
    67.05%
    24.97%
    Free Cash Flow
    43.5%
    48.73%
    72.02%
    Net Income, GAAP
    162.66%
    293.86%
    1,204.67%
    Sales/Revenue/Turnover
    21.63%
    28.93%
    33.03%
    Total Cash Common Dividend
    21.95%
    28%
    64.21%

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2016
    1,709
    2,429
    3,452
    3,806
    11,397
    2017
    3,572
    3,746
    3,698
    4,145
    15,161
    2018
    3,766
    3,920
    3,872
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2016
    2.12
    -0.71
    -1.29
    1.52
    1.28
    2017
    1.24
    0.8
    1.82
    10.26
    14.14
    2018
    1.82
    2.02
    1.76
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2016
    - -
    0.57
    - -
    0.14
    0.67
    2017
    - -
    0.78
    - -
    0.15
    0.93
    2018
    - -
    0.91
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • accessnewswire.com

      Sun Peak Provides an Update on the Shire Project

    • accessnewswire.com

      Sun Peak Provides an Update on the Shire Project

    • accesswire.com

      Sun Peak Metals to Continue Next Phase of Work on the Shire Copper-Gold VMS Project

    • prismmediawire.com

      Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

    • globenewswire.com

      Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

    • businesswire.com

      Tales of the Shire: A The Lord of The Rings Game Launches on March 25, 2025

    • globenewswire.com

      Structure Therapeutics Appoints Angus C. Russell to Board of Directors

    • accesswire.com

      Sun Peak Metals Completes Initial 2024 Drill Program at the Shire Project

    • investorplace.com

      Why I Just Made That Big Reversal on Income Investing